Amoun Pharmaceutical Company S.A.E. Sustainability Profile
Amoun Pharmaceutical Company S.A.E., commonly referred to as Amoun, is a leading player in the pharmaceutical industry, headquartered in Egypt. Established in 1975, the company has grown to become a significant contributor to the healthcare sector, with a strong presence across the Middle East and North Africa. Amoun specialises in the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including prescription medications, over-the-counter drugs, and dietary supplements. Its commitment to quality and innovation has positioned it as a trusted name in the market, with a portfolio that addresses various therapeutic areas. With numerous accolades and a robust market position, Amoun continues to enhance its reputation through strategic partnerships and a focus on research and development, ensuring it meets the evolving needs of healthcare professionals and patients alike.
DitchCarbon Score
How does Amoun Pharmaceutical Company S.A.E.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amoun Pharmaceutical Company S.A.E.'s score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Amoun Pharmaceutical Company S.A.E.'s reported carbon emissions
Amoun Pharmaceutical Company S.A.E., headquartered in Egypt (EG), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Amoun Pharmaceutical's climate commitments and emissions data may be influenced by its corporate family relationships; however, no specific initiatives or targets have been cascaded from a parent organization. The lack of available data suggests that Amoun Pharmaceutical may still be in the early stages of developing its climate strategy or reporting framework. In the broader context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are setting ambitious targets to reduce their carbon footprints. It remains to be seen how Amoun Pharmaceutical will align with these industry trends in the future.
How Carbon Intensive is Amoun Pharmaceutical Company S.A.E.'s Industry?
How Carbon Intensive is Amoun Pharmaceutical Company S.A.E.'s Location?
Amoun Pharmaceutical Company S.A.E.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Amoun Pharmaceutical Company S.A.E. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
